Splitting vaccines in small dogs remains an unsettled strategy

The question of whether veterinarians should split vaccines across multiple visits for small dogs is back in focus after a March 2026 Worms & Germs Blog post from Scott Weese, DVM, DVSc, DACVIM, who concluded that the practice might help in some circumstances, but probably doesn’t solve the underlying problem as cleanly as pet parents expect. His core message: there’s no strong evidence that splitting vaccines reliably reduces adverse events, and in some dogs it could do more harm than good if it leads to delayed protection, missed boosters, or incomplete coverage. (wormsandgermsblog.com)

The debate isn’t new. Small-breed dogs have long been recognized as having a higher risk of post-vaccination adverse events, which helps explain why pet parents often ask whether a Chihuahua or toy poodle really needs the same volume and same-day vaccine load as a large-breed dog. But current guidelines have drawn a distinction between reducing the dose and adjusting the schedule. AAHA says the full labeled dose should still be given even in small dogs, because that dose represents the minimum immunizing dose and there’s no evidence that lowering volume prevents reactions. WSAVA’s 2024 guidance makes the same point, saying half- or quarter-doses are not recommended for tiny dogs despite concern about adverse reactions. (aaha.org)

What has changed is the amount of data available on which dogs are most likely to react. A 2023 JAVMA study analyzing 4,654,187 dogs across more than 16 million vaccination visits found adverse events recorded after 31,197 visits, or 19.4 per 10,000 visits. Rates rose as the number of vaccines administered increased from one to four, were generally inversely related to body weight, and were highest in dogs weighing 5 kg or less. Rabies vaccine had the highest individual reported adverse-event rate in that dataset, and some breeds, including French Bulldogs and Dachshunds, had notably higher odds than mixed-breed dogs. (pubmed.ncbi.nlm.nih.gov)

That evidence supports why clinicians may consider spacing some products out, but it doesn’t fully validate the idea that “splitting vaccines” is broadly protective. AAHA’s FAQ on canine vaccination says combination vaccines do not inherently carry more adverse-event risk than single-component vaccines, because the proteins most associated with reactions are often non-pathogen components such as fetal calf serum, bovine serum albumin, gelatin, and casein. At the same time, AAHA does say risk can be reduced by lowering the quantity of antigenic stimulus at one visit, and specifically notes this can be particularly useful in small dogs. Its example is practical rather than ideological: give core vaccines when due, and consider delaying a noncore vaccine by about two weeks when warranted. (aaha.org)

That nuance matters, especially for leptospirosis and rabies conversations. AAHA’s canine vaccination guidelines note that adverse reactions of any type are more likely in smaller and younger dogs, but they also stress that newer leptospiral vaccines have been reformulated and that serious anaphylactic reactions have not been reported more often than for other vaccine antigens. The task force suggests starting the initial lepto dose at or after 12 weeks of age and minimizing the number of different vaccines administered at a single visit as one mitigation strategy. In other words, the guidance supports thoughtful scheduling, not reflexive avoidance. (aaha.org)

Industry and expert commentary have been moving in the same direction: individualized plans, not automatic splitting. Weese’s earlier 2025 post on half-doses made a similar argument, saying there’s no evidence that decreasing vaccine dose lowers adverse-event risk and no good data showing what that would do to immune protection. Taken together with AAHA and WSAVA guidance, the emerging consensus appears to be that veterinarians should identify which vaccines are essential now, which can safely wait, and how to counsel pet parents without undermining confidence in vaccination itself. That’s an inference from the available guidance and commentary, but it’s a well-supported one. (wormsandgermsblog.com)

Why it matters: For veterinary teams, this is a workflow and communication issue as much as a pharmacology issue. Small dogs do carry more risk of mild post-vaccination reactions, and multiple injections at one visit appear to increase that risk. But every added visit also introduces friction: more cost, more stress for the dog, more chances for a pet parent to postpone a follow-up, and more room for gaps in core protection or rabies compliance. The practical takeaway is to reserve split scheduling for clearly defined cases, such as prior vaccine reaction, very small body size, or noncore products that can safely be separated, while documenting the rationale and follow-up plan carefully. (pubmed.ncbi.nlm.nih.gov)

What to watch: The next step is likely more discussion around risk-stratified vaccine protocols for tiny and vaccine-reactive dogs, but unless stronger prospective data emerge, guideline bodies appear unlikely to endorse routine splitting or reduced doses as standard practice. (wsava.org)